Deutsch English Français

Contact

EP2435085

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2435085

EP2435085 - METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION USING A MODIFIED CLOSTRIDIAL TOXIN [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 09.01.2015 Database last updated on 14.09.2024
Most recent event Tooltip	09.01.2015	Application deemed to be withdrawn	published on 11.02.2015 [2015/07]
Applicant(s)	For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US
	[N/P]
Former [2012/14]	For all designated states Allergan, Inc. 2525 Dupont Drive, T2-7H Irvine, CA 92612 / US
Inventor(s)	01 / FRANCIS, Joseph 45 La Mirage Circle Aliso Viejo California 92656 / US
	02 / STATHAKIS, Dean G. 23 Schubert Court Irvine California 92617 / US
	[2012/14]
Representative(s)	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE
	[N/P]
Former [2012/14]	HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE
Application number, filing date	10720497.6	20.05.2010
	WO2010US35588
Priority number, date	US20090182193P	29.05.2009 Original published format: US 182193 P
	[2012/14]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2010138379
	Date:	02.12.2010
	Language:	EN
	[2010/48]
	Type:	A2 Application without search report
	No.:	EP2435085
	Date:	04.04.2012
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 02.12.2010 takes the place of the publication of the European patent application.
	[2012/14]
Search report(s)	International search report - published on:	EP	14.04.2011
Classification	IPC:	A61K47/48	[2012/14]
	CPC:	A61K38/4893 (EP,US); A61K47/6415 (EP,US); A61P25/00 (EP); A61P29/00 (EP); C12Y304/24069 (EP,US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/14]
Title	German:	VERFAHREN ZUR BEHANDLUNG CHRONISCHER NEUROGENER ENTZÜNDUNGEN MIT EINEM MODIFIZIERTEN CLOSTRIDIUM-TOXIN	[2012/14]
	English:	METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION USING A MODIFIED CLOSTRIDIAL TOXIN	[2012/14]
	French:	PROCÉDÉS DE TRAITEMENT D'INFLAMMATION NEUROGÉNIQUE CHRONIQUE PAR LE BIAIS D'ENDOPEPTIDASES À RECIBLAGE DE GALANINE	[2012/14]
Entry into regional phase	28.12.2011	National basic fee paid
	28.12.2011	Designation fee(s) paid
	28.12.2011	Examination fee paid
Examination procedure	28.12.2011	Examination requested [2012/14]
	30.07.2012	Amendment by applicant (claims and/or description)
	25.04.2014	Despatch of a communication from the examining division (Time limit: M04)
	06.09.2014	Application deemed to be withdrawn, date of legal effect [2015/07]
	30.09.2014	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/07]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.04.2014
Fees paid	Renewal fee
	25.05.2012	Renewal fee patent year 03
	28.05.2013	Renewal fee patent year 04
	Penalty fee
	Additional fee for renewal fee
	31.05.2014	05 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[IY]US2009104234 (FRANCIS JOSEPH [US], et al) [I] 1-12 * abstract * * paragraphs [0004] , [0005] , [0009] , [0011] , [0019] , [0025] , [0079] , [0188] , [0202] - [0212] * [Y] 1-12;
		[Y]WO2009055351 (ALLERGAN INC [US], et al) [Y] 1-12 * abstract * * paragraphs [0004] , [0015] , [0019] , [0035] , [0075] , [0079] , [0187] , [0197] - [0228] *;
		[Y]WO2008008805 (ALLERGAN INC [US], et al) [Y] 1-12 * abstract * * paragraphs [0012] , [0021] , [0023] , [0041] , [0134] , [0222] * * claims 1-7 *;
		[Y]US2006142181 (MILLER LANDON C [US]) [Y] 1-12 * abstract * * paragraphs [0017] , [0035] *;
		[Y]US2003165541 (DONOVAN STEPHEN [US]) [Y] 1-12 * abstract * * paragraphs [0007] , [0032] , [0033] * * examples 5-12 *
	by applicant	- JENNELLE DURNETT RICHARDSON; MICHAEL R. VASKO, "Cellular Mechanisms of Neurogenic Inflammation", J. PHARMACOL. EXP. THER., (2002), vol. 302, no. 3, pages 839 - 845
		- RICHARDSON; VASKO, J. PHARMACOL. EXP. THER., (2002), vol. 302, no. 3, pages 839 - 845
		- YANN HUMEAU ET AL., "How Botulinum and Tetanus Neurotoxins Block Neurotransmitter Release", BIOCHIMIE, (2000), vol. 82, no. 5, pages 427 - 446
		- KATHRYN TURTON ET AL., "Botulinum and Tetanus Neurotoxins: Structure, Function and Therapeutic Utility", TRENDS BIOCHEM. SCI., (2002), vol. 27, no. 11, doi:doi:10.1016/S0968-0004(02)02177-1, pages 552 - 558, XP004390740 DOI: http://dx.doi.org/10.1016/S0968-0004(02)02177-1
		- GIOVANNA LALLI ET AL., "The Journey of Tetanus and Botulinum Neurotoxins in Neurons", TRENDS MICROBIOL., (2003), vol. 11, no. 9, pages 431 - 437
		- JULIE D. THOMPSON ET AL., "CLUSTAL W: Improving the Sensitivity of Progressive Multiple Sequence Alignment Through Sequence Weighting, Position-Specific Gap Penalties and Weight Matrix Choice", NUCLEIC ACIDS RESEARCH, (1994), vol. 22, no. 22, pages 4673 - 4680, XP002956304
		- OSAMU GOTOH, "Significant Improvement in Accuracy of Multiple Protein Sequence Alignments by Iterative Refinement as Assessed by Reference to Structural Alignments", J. MOL. BIOL., (1996), vol. 264, no. 4, pages 823 - 838
		- ERIC DEPIEREUX; ERNEST FEYTMANS, "Match-Box: A Fundamentally New Algorithm for the Simultaneous Alignment of Several Protein Sequences", CABIOS, (1992), vol. 8, no. 5, pages 501 - 509
		- C. E. LAWRENCE ET AL., "Detecting Subtle Sequence Signals: A Gibbs Sampling Strategy for Multiple Alignment", SCIENCE, (1993), vol. 262, no. 5131, doi:doi:10.1126/science.8211139, pages 208 - 214, XP001152872 DOI: http://dx.doi.org/10.1126/science.8211139
		- IVO VAN WALLE ET AL., "Align-M - A New Algorithm for Multiple Alignment of Highly Divergent Sequences", BIOINFORMATICS, (2004), vol. 20, no. 9, pages 1428 - 1435
		- BURKHARD MORGENSTERN ET AL., "Multiple DNA and Protein Sequence Alignment Based On Segment-To-Segment Comparison", PROC. NATL. ACAD. SCI. U.S.A., (1996), vol. 93, no. 22, doi:doi:10.1073/pnas.93.22.12098, pages 12098 - 12103, XP002908667 DOI: http://dx.doi.org/10.1073/pnas.93.22.12098
		- CEDRIC NOTREDAME ET AL., "T-Coffee: A Novel Algorithm for Multiple Sequence Alignment", J. MOL. BIOL., (2000), vol. 302, no. 1, doi:doi:10.1006/jmbi.2000.4042, pages 205 - 217, XP004469125 DOI: http://dx.doi.org/10.1006/jmbi.2000.4042
		- ROBERT C. EDGAR, "MUSCLE: Multiple Sequence Alignment With High Score Accuracy and High Throughput", NUCLEIC ACIDS RES., (2004), vol. 32, no. 5, doi:doi:10.1093/nar/gkh340, pages 1792 - 1797, XP008137003 DOI: http://dx.doi.org/10.1093/nar/gkh340
		- AMARENDRAN R SUBRAMANIAN ET AL., "DIAUGN-T: An Improved Algorithm for Segment-Based Multiple Sequence Alignment", BMC BIOINFORMATICS, (2005), vol. 6, no. 1, doi:doi:10.1186/1471-2105-6-66, page 66, XP021000959 DOI: http://dx.doi.org/10.1186/1471-2105-6-66
		- LACY ET AL., NATURE STRUCT. BIOL., (199810), vol. 5, pages 898 - 902
		- ACHIM AIGNER, "Delivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) in vivo", J. BIOMED. BIOTECH., (2006), pages 1 - 15
		- P. D. GOOD, "Expression of Small, Therapeutic RNAs in Human Cell Nuclei", GENE THER., (1997), vol. 4, no. 1, doi:doi:10.1038/sj.gt.3300354, pages 45 - 54, XP000646610 DOI: http://dx.doi.org/10.1038/sj.gt.3300354
		- MACIEJ WIZNEROWICZ ET AL., "Tuning Silence: Conditional Systems for RNA Interference", NAT. METHODS, (2006), vol. 3, no. 9, doi:doi:10.1038/nmeth914, pages 682 - 688M, XP002491627 DOI: http://dx.doi.org/10.1038/nmeth914
		- OLA SNOVE; JOHN J. ROSSI, "Expressing Short Hairpin RNAi in vivo", NAT. METHODS, (2006), vol. 3, no. 9, doi:doi:10.1038/nmeth927, pages 689 - 698, XP055046542 DOI: http://dx.doi.org/10.1038/nmeth927
		- CHARLES X. LI ET AL., "Delivery of RNA Interference", CELL CYCLE, (2006), vol. 5, no. 18, doi:doi:10.4161/cc.5.18.3192, pages 2103 - 2109, XP055002931 DOI: http://dx.doi.org/10.4161/cc.5.18.3192
		- LARRY A. COUTURE; DAN T. STINCHCOMB, "Anti-gene Therapy: The Use of Ribozymes to Inhibit Gene Function", TRENDS GENET., (1996), vol. 12, no. 12, pages 510 - 515

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p